Clinical studies recruiting near Bryant

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Dermatology Trial Associates · Takeda · NCT07108283 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Dermatology Trial Associates · Organon and Co · NCT07265479 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · Dermatology Trial Associates · Sun Pharmaceutical Industries, Inc. · NCT07133308 Project: Every Child for Younger Patients With Cancer
Phase N/A · Children's Oncology Group · NCT02402244 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Phase 2/Phase 3 · Central Arkansas Radiation Therapy Institute, dba CARTI · Pfizer · NCT06989437 A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · National Cancer Institute (NCI) · NCT04546399 Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Phase 2 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07365462 A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Dermatology Trial Associates, Inc · Apollo Therapeutics Ltd · NCT07599813 NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Phase 3 · SanRo Clinical Research Group · Xenon Pharmaceuticals Inc. · NCT07076407 A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I
Phase 2 · Sanro Clinical Research Group /ID# 279462 · AbbVie · NCT06696755 NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06963034 Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · Children's Oncology Group · NCT03067181 Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
Phase 4 · Dermatology Trial Associates · Bausch Health Americas, Inc. · NCT07524946 Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute L
Phase 3 · Children's Oncology Group · NCT03959085 Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Phase N/A · SanRo Clinical Research Group · Bristol-Myers Squibb · NCT07379827 Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder
Phase 3 · SanRo Clinical Research Group LLC WCG Clinical Network · Janssen Research & Development, LLC · NCT06559306

Look up another city

Look up another condition